Overweight Clinical Trial
Official title:
Adaptation and Evaluation of a Family-Based Mindful Eating Intervention for Overweight Adolescents
Verified date | August 2017 |
Source | Oregon Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
With currently 35% of U.S. adolescents being overweight and one in six having metabolic syndrome, adolescent obesity is one of the major global health challenges of the 21st century. Few enduring treatment strategies have been identified in adolescent populations and the majority of standard weight loss programs fail to adequately address the impact of psychological factors on eating behavior and the beneficial contribution of parental involvement in adolescent behavior change. A critical need exists to expand treatment development efforts beyond traditional education and cognitive-behavioral programs and to explore alternative treatment models for adolescent obesity. Meditation-based mindful eating programs may represent a unique and novel scientific approach to the current adolescent obesity epidemic as they address key psychological variables affecting weight. Furthermore, the recent expansion of mindfulness programs to include family relationships shows the immense potential for broadening the customarily individual focus of this intervention to include broader factors thought to influence adolescent health outcomes. Thus, we propose to develop a mindful eating approach to eating behavior and weight loss specifically tailored for adolescents and their families. The first phase of our three phase development process will be devoted to adapting an adolescent protocol (Mindful Eating-A) based on an established mindful eating program currently being used with adult populations. We will then develop a 'family enhanced Mindful Eating-A' (Mindful Eating-A+F) protocol that integrates a family systems perspective. The goal of Mindful Eating-A+F is to expand the focus of Mindful Eating-A to include family factors that influence adolescent eating behaviors. The second design phase will consist of an initial test of both intervention components to provide feedback on usefulness and acceptability (N = 10 families). The final phase will examine the overall efficacy of the optimized Mindful Eating-A+F, relative to the Mindful Eating-A intervention with 30 overweight adolescents (BMI > 85th percentile) ages 14-17 and at least one parent. Within this examination, post-treatment and 3-month follow-up comparisons across the two treatment approaches will be made and effect sizes within and between treatments will be assessed.
Status | Completed |
Enrollment | 66 |
Est. completion date | March 2017 |
Est. primary completion date | June 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 14 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Adolescent ages 14-17 years old living at home with at least one parent/guardian, - BMI = 85th percentile, - assent from adolescent, - consent from a parent/guardian, - willingness of one parent/guardian living with adolescent to participate in the study, - English speaking. Exclusion Criteria: - Adolescent BMI = 40 (requires additional medical attention the intervention is unable to provide), - previously diagnosed type 1 or type 2 diabetes, - blood pressure in the range of stage 2 hypertension which requires medication - treatment which interferes with outcomes related to blood pressure and glucose, - medications that significantly interfere with weight gain such as oral steroid use greater than two consecutive weeks - antipsychotic medications, - participation in a standardized weight loss program within the previous 6 months, - inability to provide informed assent, - no parent/guardian consent, - insufficient reading ability to comprehend the self-administered assessment instruments (approximately 5th grade reading level). |
Country | Name | City | State |
---|---|---|---|
United States | ORI Center for Family and Adolescent Research | Albuquerque | New Mexico |
Lead Sponsor | Collaborator |
---|---|
Oregon Research Institute |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change over time: adolescent weight | Measurement of participant's weight | Week 0, Week 8, Week 20 | |
Secondary | Change over time: markers of metabolic syndrome. | Measurement of metabolic syndrome (insulin resistance, blood pressure, and dyslipidemia) | Week 0, Week 8, Week 20 | |
Secondary | Change over time: adolescent Body Mass Index | Measurement of participant's Body Mass Index | Week 0, Week 8, Week 20 | |
Secondary | Change over time: adolescent's eating behavior | Measurement of participant's eating behaviors | Week 0, Week 8, Week 20 | |
Secondary | Change over time: markers of psychological distress | Measurement of psychological distress | Week 0, Week 8, Week 20 | |
Secondary | Change over time: family barriers to healthy eating | Measurement of family barriers to healthy eating | Week 0, Week 8, Week 20 | |
Secondary | Change over time: practice of mindfulness | Measurement of participant's practice of mindfulness | Week 0, Week 8, Week 20 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 | |
Completed |
NCT03097237 -
High Fiber Rye Foods for Weight and Body Fat Reduction
|
N/A |